Clinical Trial Update: Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for sorafenib in liver function-impaired advanced hepatocellular carcinoma across Phase 2 and Phase 3 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Liver Cancer | Phase 2, Phase 3 | Status: COMPLETED